Rani Therapeutics Holdings, Inc.

US$0.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RANIHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (43.40%)
Div yield —
ROE (172.15%)
Biotechnology
Beta (5Y) 0.68
PE TTM —
TSR TTM (75.15%)
Mkt cap US$76.22M
ROIC (64.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.561
2.67%
(81.18%)
Hold 7|7|11|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
3.85%
1.96%
(4.14%)
8.05%
Revenue$M
8.547
8.392
8.405
8.211
8.81%
4.42%
3.36%
(0.71%)
Peers (US$76.22M)
Cap (US$)
PE
78.36M
—
75.71M
—
Capital
TTM
5Y
10Y
Leveragex
0.883
0.083
0.064
EBIT/Intx
4.010
1.426
1.243
Own earn%
130.53
(141.77)
(138.26)
Sh yield%
32.85
58.92
58.40
Owners
Insiders/Inst%
0.40
56.13
Short interest%
5.84
SBC / revenue%
0.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
2–11
$1 testx
—
Incr. ROIC%
36